VRTX Vertex Pharmaceuticals
$515.02 -1.08%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-1.08%
YTD
+13.60%
P/E
32.64
P/B
6.16
ROE
20.1%
Div yield
—
Beta
0.46
Market cap
$129.8B
RSI (14)
41
Next earnings
Feb 10, 2027
Same sector · Health Care
Compare VRTX with NVO and JNJ →Follow VRTX in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$529.94
Close
$515.02
Day high
$531.37
Day low
$513.80
Volume
1.8M
Latest headlines
Has Vertex Stock Become A Different Bet?
Yahoo Finance · Nov 20
2 Growth Stocks to Buy in November Without Any Hesitation
Yahoo Finance · Nov 19
Genomics, Vertex extend drug discovery alliance in $220m deal
Yahoo Finance · Nov 19
Should You Pick Vertex Stock Over Its Biotech Rivals?
Yahoo Finance · Nov 18
Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals
Yahoo Finance · Nov 18
Vertex Pharmaceuticals (VRTX) Stock May Be Undervalued After Its 187% Run
Yahoo Finance · Nov 18
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Nov 3, 2026 View → 8-K Nov 2, 2026 View → 8-K Oct 20, 2026 View → 8-K Sep 1, 2026 View → 10-Q Aug 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VRTX. Try it in the Lab to size a position and see the risk.